Status:
COMPLETED
Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer
Lead Sponsor:
Ajou University School of Medicine
Conditions:
Gastric Cancer
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
* It was confirmed that the laparoscopic surgery decreases the postoperative pain and reduces the recovery periods in the various surgical fields such as cholecystectomy and colectomy etc. Also, there...
Detailed Description
Participating Surgeons * Prior to this clinical trial, only the surgeons who are considered to have the standardization by participating the assignment entitled with "KLASS-02-QC: Standardization of ...
Eligibility Criteria
Inclusion
- The patient from over 20 years to under 80 years
- The patient with the capability for ECOG (Eastern Cooperative Oncology Group performance status) is ranged between 0 and 1
- The patient included between ASA score (American society of anesthesiology) class I and III
- The patient who is diagnosed as gastric adenocarcinoma under preoperative endoscopic biopsy
- The patient who is diagnosed as locally advanced gastric cancer with the suspicious infiltration of over muscular layer without infiltration on adjacent organs, and without or with lymph node metastasis limited to perigastric or around stomach left gastric artery at the preoperative examination.
- The patient who is suitable for subtotal resection in the preoperative examination
- The patient who is fully explained about purpose of trial and contents prior to the participation into this study and signed on the informed consent approved by Institutional Review Board according to own opinion
Exclusion
- The patient who shows distant metastasis under preoperative examination
- The patient with medical history for gastrectomy in the past
- The patient with complication (complete obstruction and perforation) by gastric cancer
- The patient who undergoes anticancer or radiologic therapy prior to the operation or who undergoes endoscopic submucous dissection for currently diagnosed gastric cancer
- The patient who undergoes surgery or anti-cancer radiologic therapy for primary cancer within 5 years
- Vulnerable patients (lack of capacity for decision making, pregnant women (or under planning))
- The patient who has participated into another clinical trial within recent 6 months or who is participating into another trial
- The patient with double cancer of activity and synchronization
Key Trial Info
Start Date :
November 21 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 2 2018
Estimated Enrollment :
1050 Patients enrolled
Trial Details
Trial ID
NCT01456598
Start Date
November 21 2011
End Date
June 2 2018
Last Update
November 29 2018
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery , SOON CHUN HYANG UNIVESITY HOSPITAL
Bucheon-si, South Korea
2
Keimyung University Dongsan Medical Center
Daegu, South Korea, 700-712
3
Copyright National Cancer Center
Goyang-si, South Korea
4
Chonnam National University Hwasun Hospital
Hwasun, South Korea, 519-809